Watchlist Manager

Watchlist

Price: 4.95 INR Market Closed

Market Cap: ₹410.4m

	Vivimed Labs Ltd NSE:VIVIMEDLAB	IN
N	NUBURU Inc AMEX:BURU	US
	Takeda Pharmaceutical Co Ltd NYSE:TAK	JP
E	Enersense International Oyj OMXH:ESENSE	FI
	Xinjiang Torch Gas Co Ltd SSE:603080	CN
C	China Isotope & Radiation Corp HKEX:1763	CN
	Profit Cultural and Creative Group Co Ltd SZSE:300640	CN
W	WeP Solutions Ltd BSE:532373	IN
P	Pioneer Global Group Ltd HKEX:224	HK
	Trent Ltd NSE:TRENT	IN
	Kweichow Moutai Co Ltd SSE:600519	CN
A	Alfi Inc OTC:ALFIQ	US

Income Statement

Currency: INR

	Mar-2009	Jun-2009	Sep-2009	Dec-2009	Mar-2010	Jun-2010	Sep-2010	Dec-2010	Mar-2011	Jun-2011	Sep-2011	Dec-2011	Mar-2012	Jun-2012	Sep-2012	Dec-2012	Mar-2013	Jun-2013	Sep-2013	Dec-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016	Dec-2016	Mar-2017	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025
Revenue
Interest Expense	173	0	0	0	212	0	0	0	219	0	0	0	284	0	0	0	409	0	0	0	603	0	0	0	790	190	378	571	816	0	0	0	610	0	0	0	0	0	0	0	570	0	0	0	581	0	0	0	505	0	0	0	385	0	0	0	350	0	0	0	10	0	0	0	0	0	0
Revenue	2 761 N/A	3 027 +10%	3 165 +5%	3 242 +2%	3 434 +6%	3 495 +2%	3 607 +3%	3 809 +6%	4 160 +9%	4 516 +9%	4 746 +5%	5 370 +13%	6 683 +24%	8 173 +22%	9 547 +17%	10 588 +11%	11 088 +5%	11 770 +6%	12 176 +3%	12 807 +5%	13 508 +5%	13 766 +2%	13 836 +1%	13 921 +1%	13 801 -1%	13 451 -3%	13 685 +2%	13 547 -1%	13 456 -1%	13 809 +3%	13 423 -3%	13 724 +2%	14 619 +7%	14 130 -3%	13 972 -1%	13 367 -4%	11 818 -12%	12 224 +3%	13 045 +7%	12 488 -4%	13 152 +5%	13 008 -1%	12 173 -6%	11 711 -4%	10 588 -10%	10 374 -2%	9 781 -6%	10 583 +8%	8 615 -19%	6 039 -30%	4 366 -28%	2 152 -51%	2 373 +10%	2 221 -6%	2 120 -5%	2 112 0%	1 871 -11%	1 723 -8%	1 618 -6%	1 475 -9%	1 491 +1%	1 431 -4%	1 342 -6%	1 293 -4%	1 163 -10%	1 083 -7%	1 041 -4%
Gross Profit
Cost of Revenue	(1 901)	(2 052)	(2 189)	(2 301)	(2 316)	(2 275)	(2 337)	(2 406)	(2 745)	(2 837)	(2 916)	(3 132)	(4 408)	(3 838)	(4 398)	(4 969)	(7 708)	(5 809)	(6 091)	(6 295)	(9 662)	(6 519)	(6 415)	(6 394)	(8 330)	(6 213)	(6 327)	(6 257)	(7 898)	(6 478)	(6 226)	(5 973)	(7 356)	(5 018)	(4 729)	(4 757)	(4 797)	(4 850)	(5 291)	(4 902)	(7 757)	(5 340)	(5 219)	(5 161)	(6 741)	(4 391)	(3 862)	(4 209)	(4 944)	(2 545)	(2 096)	(1 327)	(1 793)	(1 743)	(1 585)	(1 553)	(3 016)	(2 620)	(2 559)	(2 396)	(871)	(721)	(658)	(637)	(599)	(523)	(500)
Gross Profit	860 N/A	975 +13%	976 +0%	941 -4%	1 118 +19%	1 220 +9%	1 270 +4%	1 404 +11%	1 415 +1%	1 679 +19%	1 830 +9%	2 238 +22%	2 275 +2%	4 335 +91%	5 148 +19%	5 619 +9%	3 380 -40%	5 962 +76%	6 085 +2%	6 512 +7%	3 847 -41%	7 247 +88%	7 421 +2%	7 527 +1%	5 471 -27%	7 238 +32%	7 357 +2%	7 290 -1%	5 559 -24%	7 331 +32%	7 197 -2%	7 751 +8%	7 263 -6%	9 113 +25%	9 243 +1%	8 610 -7%	7 021 -18%	7 373 +5%	7 754 +5%	7 586 -2%	5 394 -29%	7 669 +42%	6 954 -9%	6 550 -6%	3 847 -41%	5 983 +56%	5 919 -1%	6 374 +8%	3 671 -42%	3 495 -5%	2 270 -35%	825 -64%	580 -30%	479 -17%	535 +12%	559 +5%	(1 145) N/A	(896) +22%	(942) -5%	(921) +2%	619 N/A	709 +15%	684 -4%	656 -4%	564 -14%	560 -1%	541 -3%
Operating Income
Operating Expenses	(463)	(527)	(497)	(508)	(578)	(663)	(666)	(693)	(630)	(867)	(971)	(1 358)	(1 240)	(3 090)	(3 842)	(4 354)	(2 255)	(4 842)	(4 923)	(5 194)	(2 734)	(5 765)	(5 962)	(6 020)	(3 985)	(5 624)	(5 642)	(5 545)	(3 980)	(5 645)	(5 471)	(5 618)	(3 855)	(5 621)	(5 748)	(5 611)	(5 467)	(5 829)	(6 369)	(6 336)	(4 662)	(6 853)	(6 648)	(6 703)	(4 371)	(6 520)	(6 274)	(6 868)	(3 633)	(3 983)	(2 885)	(1 174)	(843)	(935)	(976)	(975)	(915)	(1 982)	(1 908)	(1 872)	(870)	(1 342)	(1 259)	(1 252)	(897)	(795)	(788)
Selling, General & Administrative	(385)	(183)	(177)	(181)	(483)	(223)	(236)	(254)	(454)	(202)	(221)	(239)	(867)	(436)	(489)	(499)	(1 667)	(516)	(557)	(654)	(2 073)	(975)	(1 233)	(1 520)	(3 141)	(1 827)	(1 782)	(1 687)	(3 182)	(1 817)	(1 853)	(1 972)	(3 273)	(1 826)	(1 856)	(1 878)	(1 935)	(2 087)	(2 301)	(2 201)	(3 993)	(2 451)	(2 293)	(2 357)	(3 701)	(2 337)	(2 371)	(2 581)	(3 078)	(1 366)	(920)	(316)	(412)	(343)	(333)	(335)	(392)	(336)	(357)	(360)	(425)	(326)	(291)	(266)	(284)	(281)	(274)
Depreciation & Amortization	(71)	(74)	(66)	(60)	(87)	(87)	(97)	(101)	(102)	(99)	(116)	(169)	(268)	(383)	(486)	(560)	(588)	(593)	(626)	(653)	(661)	(680)	(671)	(686)	(662)	(645)	(643)	(613)	(614)	(625)	(604)	(605)	(583)	(550)	(567)	(552)	(564)	(597)	(632)	(646)	(668)	(679)	(652)	(655)	(669)	(673)	(680)	(689)	(555)	(427)	(295)	(175)	(183)	(182)	(179)	(174)	(191)	(1 087)	(1 093)	(1 100)	(199)	(193)	(186)	(206)	(202)	(212)	(220)
Other Operating Expenses	(6)	(270)	(254)	(267)	(9)	(353)	(334)	(337)	(74)	(566)	(635)	(950)	(105)	(2 271)	(2 868)	(3 296)	0	(3 732)	(3 739)	(3 887)	0	(4 111)	(4 058)	(3 814)	(182)	(3 153)	(3 217)	(3 245)	(184)	(3 203)	(3 013)	(3 042)	0	(3 245)	(3 325)	(3 181)	(2 969)	(3 145)	(3 435)	(3 490)	0	(3 724)	(3 704)	(3 691)	0	(3 510)	(3 223)	(3 598)	0	(2 189)	(1 670)	(684)	(248)	(409)	(464)	(465)	(331)	(559)	(458)	(411)	(246)	(824)	(782)	(780)	(411)	(303)	(293)
Operating Income	397 N/A	448 +13%	479 +7%	433 -9%	539 +24%	557 +3%	604 +9%	711 +18%	785 +10%	813 +4%	859 +6%	880 +2%	1 035 +18%	1 245 +20%	1 306 +5%	1 265 -3%	1 125 -11%	1 120 0%	1 162 +4%	1 318 +13%	1 113 -16%	1 483 +33%	1 460 -2%	1 507 +3%	1 486 -1%	1 614 +9%	1 715 +6%	1 745 +2%	1 579 -10%	1 687 +7%	1 726 +2%	2 133 +24%	3 408 +60%	3 492 +2%	3 495 +0%	2 999 -14%	1 554 -48%	1 544 -1%	1 385 -10%	1 250 -10%	733 -41%	816 +11%	306 -63%	(154) N/A	(524) -241%	(537) -2%	(355) +34%	(494) -39%	38 N/A	(489) N/A	(615) -26%	(349) +43%	(263) +25%	(456) -73%	(441) +3%	(415) +6%	(2 060) -396%	(2 878) -40%	(2 850) +1%	(2 793) +2%	(251) +91%	(633) -152%	(575) +9%	(596) -4%	(333) +44%	(236) +29%	(247) -5%
Pre-Tax Income
Interest Income Expense	(169)	(205)	(225)	(209)	(174)	(197)	(186)	(189)	(226)	(234)	(275)	(273)	(280)	(378)	(406)	(446)	(265)	(349)	(413)	(471)	(326)	(688)	(733)	(770)	(769)	(797)	(769)	(768)	(687)	(777)	(739)	(720)	(575)	(749)	(817)	(815)	(792)	(743)	(702)	(706)	(200)	(601)	(581)	(570)	(578)	(617)	(597)	(594)	(801)	(485)	(435)	(389)	(386)	(396)	(398)	(374)	(350)	(373)	(403)	(443)	(23)	79	194	321	(17)	(32)	(45)
Non-Reccuring Items	0	0	0	0	0	0	0	0	(14)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(893)	0	0	0	0	0	0	0	0	0	0
Gain/Loss on Disposition of Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(69)	0	0	0	0	0	0	0	0	0	0	0	(4)	0	0	0	(269)	0	0	0	0	0	0
Total Other Income	3	31	31	68	31	59	59	21	8	10	11	26	24	74	171	177	119	132	41	24	82	63	107	111	59	61	56	66	108	112	76	87	32	90	90	91	96	127	167	199	127	185	159	117	75	88	82	105	65	89	72	25	1	4	4	9	1	11	30	30	85	98	78	78	32	47	49
Pre-Tax Income	231 N/A	274 +19%	285 +4%	292 +3%	396 +35%	419 +6%	477 +14%	543 +14%	553 +2%	589 +7%	595 +1%	633 +6%	778 +23%	942 +21%	1 071 +14%	996 -7%	979 -2%	903 -8%	791 -12%	871 +10%	869 0%	857 -1%	834 -3%	848 +2%	775 -9%	878 +13%	1 002 +14%	1 043 +4%	999 -4%	1 021 +2%	1 063 +4%	1 500 +41%	2 865 +91%	2 833 -1%	2 769 -2%	2 275 -18%	857 -62%	928 +8%	851 -8%	744 -13%	660 -11%	399 -39%	(116) N/A	(607) -423%	(1 095) -80%	(1 066) +3%	(870) +18%	(983) -13%	(699) +29%	(884) -26%	(978) -11%	(713) +27%	(648) +9%	(848) -31%	(835) +1%	(781) +6%	(3 307) -323%	(3 240) +2%	(3 222) +1%	(3 205) +1%	(458) +86%	(455) +1%	(303) +33%	(197) +35%	(318) -62%	(221) +31%	(243) -10%
Net Income
Tax Provision	(38)	(53)	(60)	(50)	(86)	(80)	(84)	(96)	(64)	(75)	(93)	(103)	(147)	(173)	(171)	(87)	(143)	(128)	(108)	(167)	(205)	(222)	(198)	(197)	(55)	(87)	(136)	(153)	(163)	(150)	(154)	(304)	(725)	(730)	(722)	(536)	(96)	(121)	(82)	(76)	(87)	(9)	60	122	4	1	(67)	(129)	(20)	14	11	4	(28)	(28)	(28)	(28)	21	33	33	38	4	(8)	(8)	0	(2)	(1)	(1)
Income from Continuing Operations	194	221	226	243	310	339	393	447	488	514	503	530	631	769	900	909	836	774	683	703	664	635	636	651	721	791	866	890	837	871	909	1 196	2 140	2 103	2 047	1 739	761	807	769	668	574	390	(56)	(485)	(1 091)	(1 064)	(937)	(1 112)	(719)	(871)	(967)	(709)	(677)	(875)	(862)	(809)	(3 285)	(3 207)	(3 190)	(3 167)	(454)	(463)	(312)	(211)	(321)	(221)	(243)
Income to Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income (Common)	194 N/A	221 +14%	226 +2%	243 +8%	310 +28%	339 +9%	393 +16%	447 +14%	488 +9%	514 +5%	503 -2%	530 +5%	631 +19%	769 +22%	900 +17%	909 +1%	836 -8%	774 -7%	683 -12%	703 +3%	664 -6%	635 -4%	636 +0%	651 +2%	721 +11%	791 +10%	866 +9%	890 +3%	837 -6%	871 +4%	909 +4%	1 196 +32%	2 140 +79%	2 103 -2%	2 047 -3%	1 739 -15%	779 -55%	825 +6%	787 -5%	686 -13%	574 -16%	390 -32%	(56) N/A	(485) -768%	(1 091) -125%	(1 064) +2%	(937) +12%	(1 112) -19%	(719) +35%	(871) -21%	(967) -11%	(709) +27%	(677) +4%	(875) -29%	(862) +1%	(809) +6%	(3 285) -306%	(3 207) +2%	(3 190) +1%	(3 167) +1%	(454) +86%	(463) -2%	(312) +33%	(211) +32%	(320) -51%	(222) +31%	(244) -10%
EPS (Diluted)	4.12 N/A	4.71 +14%	4.53 -4%	4.87 +8%	6.32 +30%	6.79 +7%	7.89 +16%	8.79 +11%	9.56 +9%	8.49 -11%	4.97 -41%	6.6 +33%	9.01 +37%	7.44 -17%	8.73 +17%	11.32 +30%	10.45 -8%	9.56 -9%	8.33 -13%	8.7 +4%	8.19 -6%	7.83 -4%	7.76 -1%	8.04 +4%	8.89 +11%	9.77 +10%	10.69 +9%	10.99 +3%	10.33 -6%	10.44 +1%	10.75 +3%	14.32 +33%	25.47 +78%	25.17 -1%	24.22 -4%	20.77 -14%	9.05 -56%	9.88 +9%	9.14 -7%	7.98 -13%	6.67 -16%	4.57 -31%	-0.67 N/A	-5.85 -773%	-13.16 -125%	-12.43 +6%	-11.3 +9%	-13.41 -19%	-8.67 +35%	-10.43 -20%	-11.67 -12%	-8.55 +27%	-8.16 +5%	-10.56 -29%	-10.41 +1%	-9.71 +7%	-39.62 -308%	-38.69 +2%	-38.49 +1%	-38.28 +1%	-5.48 +86%	-5.6 -2%	-3.77 +33%	-2.55 +32%	-3.85 -51%	-2.68 +30%	-2.94 -10%

Income Statement Balance Sheet Cash Flow Statement

Vivimed Labs Ltd
NSE:VIVIMEDLAB

Income Statement

Earnings Waterfall
Vivimed Labs Ltd

Income Statement
Vivimed Labs Ltd

See Also

Company

Help

Tools

Stocks

Vivimed Labs Ltd NSE:VIVIMEDLAB

Income Statement

Earnings Waterfall Vivimed Labs Ltd

Income Statement Vivimed Labs Ltd

See Also

Company

Help

Tools

Stocks

Vivimed Labs Ltd
NSE:VIVIMEDLAB

Earnings Waterfall
Vivimed Labs Ltd

Income Statement
Vivimed Labs Ltd